Skip to Main Content
  • Login
  • Contact Us
  • Donate

NANETS

  • About
    • Mission
    • Board of Directors
    • Committees
    • NANETS Presidents
    • Lifetime Achievement
    • Outstanding Service
    • History
    • Diversity Statement
  • Education
    • NETCast Podcast Series
    • 2023 NET Medical Symposium
    • Regional NET Education
    • Virtual Programming Series
    • Upcoming Symposia
    • Conference Archives
    • NETMed Webinar Archives
    • About NETs
  • Research
    • Abstracts Library
    • Abstract Instructions
    • Research Grants
    • Grant Recipients
    • Grant Instructions
  • Guidelines
  • Resources
    • Grant Resources
    • NANETS Mentorship Program
    • Employment Postings
    • Clinical Trials
    • Member DirectoryMember Directory
    • NET Around the World
    • Patient Resources
    • Women in NETs
    • COVID-19 Resource Page
    • NANETS Collaboration Submission Form
  • News
    • NET eNews
    • Media
    • Endocrine-Related CancerEndocrine-Related Cancer
    • Photo Gallery
  • Membership
    • Member Login
    • Member Benefits
    • Member Categories
    • Join NOW
    • Code of Conduct
  • 2022

  • 2021

  • 2020

  • 2019

  • 2018

  • 2017

  • 2016

  • 2015

  • 2014

  • 2013

  • 2012

  • 2011

  • 2010

  • 2009

All Abstracts NANETS 2021 Virtual Symposium

Published in 2021

Download

[B10] Haas - Novel Fusion Gene UBTF-MAML3 Drives Tumorigenesis in Neuroendocrine Tumor Cells

Published in 2021 Listed under Poster

Download

[B11] Guenter - Variability of Somatostatin Receptor Type 2 Immunohistochemical Staining Patterns Among

Published in 2021 Listed under Poster

Download

[B12] Keutgen - Sunitinib-loaded Chondroitin Sulfate Hydrogels as a Novel Drug-delivery Mechanism for the Treatment of Pancreatic

Published in 2021 Listed under Poster

Download

[B13] Jacenik - The MAP Kinase-activated Protein Kinase 2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Involving Action Mediated by

Published in 2021 Listed under Poster

Download

[B14] Beyer - Establishment of Two Patient-derived Neuroendocrine Carcinoma Spheroid and Xenograft Models for Drug Testing

Published in 2021

Download

[B15] Tran - Comparison of Drug Sensitivity Profiles of Various NEN Spheroids

Published in 2021 Listed under Poster

Download

[B16] Chauhan - Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma

Published in 2021 Listed under Poster

Download

[B17] Liu - Pre-clinical Evaluation of Alpha-particle Radiotherapy Targeting CXCR4 in Small Cell Lung Cancer

Published in 2021 Listed under Poster

Download

[B1] Ivanov - Sex-specific Transcriptional Differences and Loss of Gene Imprinting in Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[B2] Tran - RNA-sequencing Identifies Unique Molecular Features of Duodenal Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[B3] Guo - Cd36 Mediated Metabolic Reprogramming in Cancer Stem Cells Contributes to Drug Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[B4] Keutgen - Loss of MEN1 Function Inhibits DNA Repair Capability of Pancreatic Neuroendocrine Tumors after Radiation

Published in 2021 Listed under Poster

Download

[B5] Shaikamjad - RABL6A-Myc Signaling Promotes Pancreatic Neuroendocrine Tumor Cell Proliferation and Survival

Published in 2021 Listed under Poster

Download

[B6] Ear - Inhibition of Serotonin Biosynthesis Suppresses Tumor

Published in 2021 Listed under Poster

Download

[B7] Armstrong - Succinate Accumulation Is Not Sufficient for Tumorigenesis in Mouse Chromaffin Cells But Dual Loss of SDHB and NF1 Yields SDHx-like Pheochromocytomas

Published in 2021 Listed under Poster

Download

[B8] Tow - Development of a Real-time Luminescent Sensor for Detecting Serotonin Levels in Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[B9] Whitt - Natural Compound Verrucarin A Potentiates the Anticancer Effect of Etoposide in NET Cell Lines

Published in 2021 Listed under Poster

Download

[C10] McGarrah - Genomic Profiling of Responders and Non-responders to Checkpoint Inhibition in Neuroendocrine Carcinoma

Published in 2021 Listed under Poster

Download

[C11] Desai - Lurbinectedin in Extrapulmonary Metastatic Neuroendocrine Carcinomas

Published in 2021 Listed under Poster

Download

[C12] Khuong Le - Urinary Neuroendocrine Neoplasms (NENs) Treated in the "Modern Era": A Multicenter Retrospective Review

Published in 2021 Listed under Poster

Download

[C13] Bai - Health-related Quality-of-life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)

Published in 2021 Listed under Poster

Download

[C14] Mohamed - Exploring Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Published in 2021 Listed under Poster

Download

[C15] Al-Toubah - Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C16] Al-Toubah - Efficacy of Ipilimumab and Nivolumab in Patients with Highgrade Neuroendocrine Neoplasms

Published in 2021 Listed under Poster

Download

[C17] Hauser - Treatment Response and Clinical Outcomes of Neuroendocrine Neoplasms (NENs) Treated with Immune Checkpoint Inhibitors (ICIs): a Single Institution Experience

Published in 2021 Listed under Poster

Download

[C18] Shen - A Phase 2 Study of Surufatinib in Combination with Toripalimab in Patients with Advanced Neuroendocrine Carcinoma

Published in 2021 Listed under Poster

Download

[C19] Chan - Phase 2 Trial of Pembrolizumab-based Therapy in Previously Treated Extrapulmonary Poorly-differentiated Neuroendocrine Carcinomas: Results of Part B

Published in 2021 Listed under Poster

Download

[C1] Gile - Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy in Patients with High-grade Extrapulmonary

Published in 2021 Listed under Poster

Download

[C20] Raj - Randomized Blinded Study Comparing Injection Site Pain From Octreotide Long-acting-release (LAR) Versus Lanreotide During the Treatment of Well-differentiated

Published in 2021 Listed under Poster

Download

[C21] Das - Validation of a Clinical Score (CS) for Patients With WellDifferentiated Neuroendocrine Tumors (WD NETs) Under Consideration for Peptide Receptor Radionuclide Therapy

Published in 2021 Listed under Poster

Download

[C22] Attiyeh - Defining MRI Superiority Over CT for Neuroendocrine Liver Metastases

Published in 2021 Listed under Poster

Download

[C23] Wong - Long-term Outcomes Following 90YRadioembolization of Neuroendocrine Liver Metastases

Published in 2021 Listed under Poster

Download

[C24] Badawy - Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS)

Published in 2021 Listed under Poster

Download

[C25] Weekley - Comparing Periprocedural Hemodynamic Instability in Y-90 Radioembolization and Bland Embolization for Neuroendocrine Tumor Liver Metastases

Published in 2021 Listed under Poster

Download

[C26] Duan - Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single

Published in 2021 Listed under Poster

Download

[C27] Zhou - Subgroup Analysis by Ki-67 and Primary Tumor Origins of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Extrapancreatic Neuroendocrine Tumors (SANET-ep)

Published in 2021 Listed under Poster

Download

[C28] Yu - Subgroup Analysis by Ki-67 and Baseline CgA of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Pancreatic

Published in 2021 Listed under Poster

Download

[C29] Clement - Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Advanced Pancreatic Neuroendocrine Tumours (panNETs): Data From the NETTER-R International,

Published in 2021 Listed under Poster

Download

[C2] Mohamed - The Role of Microbiome in Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs)

Published in 2021 Listed under Poster

Download

[C30] Halfdanarson - Compose: Pivotal Phase III Trial of 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade 2 and Grade 3 Gastroenteropancreatic

Published in 2021 Listed under Poster

Download

[C31] Grønbæk - Safety and Effectiveness of 177Lu-Satoreotide Tetraxetan in Patients with Progressive Neuroendocrine Tumors (NETs): Interim Analysis of a Phase I/II Study

Published in 2021 Listed under Poster

Download

[C32] Kunz - The Phase 3 NETTER-1 Study of 177Lu-DOTATATE in Patients with Midgut Neuroendocrine Tumors: Updated

Published in 2021 Listed under Poster

Download

[C33] Norman - Utility of Midpoint Imaging in Patients Receiving Peptide Receptor Radionuclide Therapy (PRRT) for Advance Progressive Gastroenteropancreatic-Neuroendocrine

Published in 2021 Listed under Poster

Download

[C34] Pryma - Secondary Hematological Malignancies Following Highspecific Activity Iodine-131 Metaiodobenzylguanidine Treatment of Advanced Pheochromocytoma and

Published in 2021 Listed under Poster

Download

[C35] Manohar - 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: a Single Center Experience

Published in 2021 Listed under Poster

Download

[C36] Soulen - Cap-Tem-Y90 for Grade 2 Liver-dominant Net Metastases

Published in 2021 Listed under Poster

Download

[C37] Coffman - Treatment Response and Clinical Outcomes of Well-differentiated (WD) High-grade (HG) Neuroendocrine Tumors (NETs) to 177Lu-DOTATATE

Published in 2021 Listed under Poster

Download

[C38] Lawhn-Heath - Clinical Utility of Qualitative Post-treatment SPECT After Peptide Receptor Radionuclide Therapy

Published in 2021 Listed under Poster

Download

[C39] Bodei - Blood-based Genomic Assessment of Clinical Efficacy and Toxicity of 177Lu-DOTATATE of Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C3] Li - Patient-reported Clinical and Productivity Outcomes From the Longitudinal Telotristat Ethyl Treatment Registry

Published in 2021 Listed under Poster

Download

[C40] Gococo-Benore - Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients

Published in 2021 Listed under Poster

Download

[C41] Gupta - Concurrent Everolimus with Hepatic Transarterial Bland Embolotherapy [Evero-Embo] in Patients with Bulky and/or Progressive Metastatic Well Differentiated Neuroendocrine

Published in 2021 Listed under Poster

Download

[C42] Zan - A Case of G3-WD Gastric Carcinoid Tumor in a MEN1 Patient with Discrepant Treatment Response to PRRT in

Published in 2021 Listed under Poster

Download

[C43] Malhotra - MRI Has Improved Detection of Small Neuroendocrine Liver Metastasis Compared with Ga-68 DOTATATE

Published in 2021 Listed under Poster

Download

[C44] Gudmundsdottir - Multifocality Is Not Associated with Worse Survival in Sporadic Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C45] Tran - Management of Duodenal Neuroendocrine Tumors: Surgical Versus Endoscopic Mucosal Resection

Published in 2021 Listed under Poster

Download

[C46] Gudmundsdottir - Alternative Lengthening of Telomeres Is Associated with Aggressive Pathologic Features and Increased Recurrence Risk in Large Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C47] Shi - Pathologic Features of Small Pancreatic Neuroendocrine Tumors with Liver Metastasis

Published in 2021 Listed under Poster

Download

[C48] Shi - Venous Invasion in Resected Pancreatic Neuroendocrine Tumors Is Independently Associated with Disease Free

Published in 2021 Listed under Poster

Download

[C49] Watanabe - Importance of Grade in the Surgical Management of Rectal Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C4] Littlejohn - An Open-Label, Phase II Investigation of Trifluridine/Tipiracil in Patients With High-Grade, Extrapulmonary

Published in 2021

Download

[C50] Slattery - Detection Method and Overall Survival in Surgically Resected Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C51] Naaseh - A Single-Center Experience in Observation of Small Pancreatic Neuroendocrine Tumors: To Operate or Not to

Published in 2021 Listed under Poster

Download

[C52] Nguyen - Role of Chromogranin A in the Diagnosis and Follow up of Neuroendocrine Neoplasms: Real World Review

Published in 2021 Listed under Poster

Download

[C53] Pommier - A Prospective Study of Carcinoid Crisis with No Perioperative Octreotide

Published in 2021 Listed under Poster

Download

[C54] Herring - Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors from Black and White

Published in 2021 Listed under Poster

Download

[C55] Pulvirenti - Early Onset Well Differentiated Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathologic Features, and

Published in 2021 Listed under Poster

Download

[C56] DiPeri - Comparison of Patients with Small Bowel Neuroendocrine Tumor Liver Metastaseswith and without Carcinoid Syndrome: A Single Institutional Analysis

Published in 2021 Listed under Poster

Download

[C57] Chauhan - HPG80 (circulating progastrin), a Novel Blood-based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated

Published in 2021 Listed under Poster

Download

[C5] Li - Interim analysis results of surufatinib in US patients with neuroendocrine tumors (NETs)

Published in 2021 Listed under Poster

Download

[C6] Guo - Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C7] Halperin - The Safety and Efficacy of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate in Patients (Pts) with Advanced GI Mid-gut Neuroendocrine Tumor (NET): Phase 2 Results

Published in 2021 Listed under Poster

Download

[C8] Reidy-Lagunes - Lanreotide Autogel/Depot (LAN) in Patients with Advanced Bronchopulmonary (BP) Neuroendocrine Tumors (NETs): Results From the Phase 3 SPINET Study

Published in 2021 Listed under Poster

Download

[C9] Siddiqui - Real World Use of Lanreotide in Management of Neuroendocrine Tumours

Published in 2021 Listed under Poster

Download

[O1] Das - A Systematic Survey of Two Decades of Clinical Trials in Neuroendocrine Neoplasms (NENs)

Published in 2021 Listed under Poster

Download

[O2] Yen - The Feasibility and Acceptability of Health and Wellness Coaching for Neuroendocrine Tumor Patients and Their

Published in 2021 Listed under Poster

Download

[O3] Hallet - Patient-reported Cognitive and Psychological Screening in Neuroendocrine Tumors (NETs) - a Prospective Cohort

Published in 2021 Listed under Poster

Download

[O4] Kolarova - Neuroendocrine Tumor Treatments and Follow-up Disease Management - Comparative Perspective (U.S. and Canada

Published in 2021 Listed under Poster

Download

[O5] Hickman - Outcomes of Initial Treatment in Early Stage Neuroendocrine Carcinoma of the Uterine Cervix (NCUC)

Published in 2021 Listed under Poster

Download

[O6] Tsang - Evaluating the Association Between Family History and Overall Survival Among Patients with Gastrointestinal and Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[O7] Wachtel - Succinate Dehydrogenase Pathogenic Variants are Not Associated with Non-canonical Cancers

Published in 2021 Listed under Poster

Download

[O8] Anaka - Understanding Neuroendocrine Tumour Patient Preferences for Medical Management of Midgut NETs Using Discrete Choice Experiments: a DIRECT NETs Study

Published in 2021 Listed under Poster

Download

[P10] Rakshit - Covid-19 in Patients with Neuroendocrine Tumors (NETs): the Mayo Clinic Experience

Published in 2021 Listed under Poster

Download

[P11] Abdelrahman - The Epidemiology of Mixed Acinar Neuroendocrine Carcinoma of the Pancreas in the United States

Published in 2021 Listed under Poster

Download

[P12] Albor - MDT Experience in Argentina in Nets in Times of the Covid19 Pandemic

Published in 2021 Listed under Poster

Download

[P1] Wong - Predictors And Outcomes Of Minimally Invasive Surgery For Small Bowel Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P2] Hallet - Incidence of Psychiatric Illness in Patients With Neuroendocrine Tumors - A Comparative Population-Based

Published in 2021 Listed under Poster

Download

[P3] Bateni - Incidence and Predictors of Second Cancers in Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P4] Bateni - Secondary Primary Cancers and Survival among Neuroendocrine Tumor Patients

Published in 2021 Listed under Poster

Download

[P5] Zarate Rodriguez - Race is an Independent Predictor for Surgery Offer in Patients with Small Bowel Neuroendocrine Tumors But Not Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P6] Zarate Rodriguez - Surgical Interventions in Patients with Pancreatic Neuroendocrine Tumors: a SEER-based Survival Analysis

Published in 2021 Listed under Poster

Download

[P7] Lee - Prevalence and Presentation of Cushing and Carcinoid Syndromes in Patients with Non-metastatic Primary Lung

Published in 2021 Listed under Poster

Download

[P8] Harsha Tella - Association Between Hospital Volume and Overall Survival of Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P9] Mulvey - The Impact of Sociodemographic Factors on Overall Survival for Patients with Adrenocortical Carcinomas in California

Published in 2021 Listed under Poster

Download

[T1] El-Rayes - Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects with Advanced Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[T2] Lagast - Dose Selection for Paltusotine, a Once Daily Oral Nonpeptide, Somatostatin Receptor 2 Ligand, for the Treatment of Patients with Carcinoid Syndrome (CS)

Published in 2021 Listed under Poster

Download

[T3] Singh - [177Lu]Lu-DOTA-TATE as First-line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): the NETTER-2 Study

Published in 2021 Listed under Poster

Download

[T4] O'Dorisio - A Phase II Trial to Evaluate the Safety and Dosimetry of [177Lu]Lu-DOTA-TATE in Adolescent Patients with Somatostatin Receptor (SSTR)-positive Gastroenteropancreatic Neuroendocrine Tumors (GEP

Published in 2021 Listed under Poster

Download

[T5] Chauhan - ETCTN 10388: a Phase 1 Trial of Triapine and Lutetium 177 Dotatate in Well-differentiated Somatostatin Receptorpositive Gastroenteropancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download
  • 1
  • 2
  • »

NANETS

136 Everett Rd | Albany, NY 12205
(650) 7NANETS or (518) 465-4549 | staff@nanets.net

Member Login

Twitter Facebook LinkedIn
  • Privacy Policy
  • |
  • Site Map

Copyright ©2023 ADG. All Rights Reserved | Web Design & Development by ADG Creative, a division of ADG.
ADG is a certified Women Owned Business.